Michael Matly M.d.

Michael Matly M.D. is a seasoned healthcare professional with extensive experience in investment and venture capital. Currently serving as Co-Founder and Managing Partner at 111° West Capital, Michael is also involved as an investor with KODE Health, Cherry, Codoxo, and Arine, where Michael additionally holds a board member position. Previous roles include being a venture advisor at Rock Health Capital and a board member at Orexo AB publ, having also contributed to TigerConnect, Tebra, and Pure Life Renal as an investor and board member. Michael's academic credentials include an M.B.A. from Harvard Business School and a Doctor of Medicine degree from Mayo Clinic Alix School of Medicine.